FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

53136009: Chloroquine phosphate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
88386015 Chloroquine phosphate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
791222019 Chloroquine phosphate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
24261000188119 Chloroquine phosphate fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Chloroquine phosphate Is a Product containing chloroquine (medicinal product) false Inferred relationship Some
Chloroquine phosphate Is a Chloroquine (substance) false Inferred relationship Some
Chloroquine phosphate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Amebicide (disposition) false Inferred relationship Some
Chloroquine phosphate Is a Aminoquinoline antimalarial true Inferred relationship Some
Chloroquine phosphate Is a Amoebicide false Inferred relationship Some
Chloroquine phosphate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Chloroquine (substance) true Inferred relationship Some
Chloroquine phosphate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antimalarial (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Chloroquine phosphate 250 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chloroquine phosphate Inferred relationship Some
Chloroquine phosphate 80mg/5mL syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chloroquine phosphate Inferred relationship Some
Chloroquine phosphate 50mg/mL injection 5mL ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chloroquine phosphate Inferred relationship Some
Chloroquine phosphate 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chloroquine phosphate Inferred relationship Some
Proguanil hydrochloride 100mg tablet and chloroquine phosphate 250mg tablet pack The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chloroquine phosphate Inferred relationship Some
Proguanil hydrochloride+chloroquine phosphate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chloroquine phosphate Inferred relationship Some
Chloroquine phosphate 250 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chloroquine phosphate Inferred relationship Some 1
Chloroquine phosphate 250 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Chloroquine phosphate Inferred relationship Some 1
Chloroquine phosphate 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Chloroquine phosphate Inferred relationship Some 1
Chloroquine phosphate 500 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Chloroquine phosphate Inferred relationship Some 1
Chloroquine phosphate 500 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Chloroquine phosphate Inferred relationship Some 1
Chloroquine phosphate 250 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Chloroquine phosphate Inferred relationship Some 1
Product containing precisely chloroquine phosphate 16 milligram/1 milliliter conventional release oral solution (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Chloroquine phosphate Inferred relationship Some 1
Product containing precisely chloroquine phosphate 16 milligram/1 milliliter conventional release oral solution (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Chloroquine phosphate Inferred relationship Some 1
Chloroquine phosphate 160 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Chloroquine phosphate Inferred relationship Some 1
Chloroquine phosphate 160 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Chloroquine phosphate Inferred relationship Some 1

This concept is not in any reference sets

Back to Start